why choose us

First received: November 08, 2023

Clinical Trial: Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: SARS-CoV-2

Study Type: OBSERVATIONAL


Official Title: COMIRNATY Intramuscular Injection for 6 Months to 4 Years Old (Monovalent: Omicron XBB.1.5) Special Investigation for Booster Immunization in Children Aged 6 Months to 4 Years

Brief Summary: The purpose of this post-marketing study is to assess the safety of Comirnaty monovalent XBB.1.5.for booster vaccination children ages 6 months though 4 years under actual use medical practice.

Read more